1. Chang CC, Harrison TS, Bicanic TA, Chayakulkeeree M, Sorrell TC, Warris A, et al. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and
ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024;24(8):e495-e512.
2. Chen SC, Perfect J, Colombo AL, Cornely OA, Groll AH, Seidel D, et al. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation
with ISHAM and ASM. Lancet Infect Dis. 2021;21(12):e375-e86.
3. Gülmez D, Alp Ş. Mantar İnfeksiyonlarının Laboratuvar Tanısında Klasik Yöntemler ve Yeni Gelişmeler. Flora. 2021;26:34-49.
4. Alp S, Gulmez D, Ayaz CM, Arikan-Akdagli S, Akova M. Fungaemia due to rare yeasts in a tertiary care university centre within 18 years. Mycoses. 2020;63:488-93.
5. Oz Y, Yilmaz M, Bulduk T, Basayigit M, Gunduz E, Metintas S. Comparison of fungemia caused by Candida and non-Candida rare yeasts: a retrospective study from a tertiary care hospital.
Med Mycol. 2024;62 myae037.
6. Rathore SS, Sathiyamoorthy J, Lalitha C, Ramakrishnan J. A holistic review on Cryptococcus neoformans. Microb Pathog. 2022;166:105521.
7. Takashima M, Sugita T. Taxonomy of Pathogenic Yeasts Candida, Cryptococcus, Malassezia, and Trichosporon. Med Mycol J. 2022;63:119-32.
8. WHO. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Geneva: World Health Organization; 2022.
9. Hagen F, Lumbsch HT, Arsic Arsenijevic V, Badali H, Bertout S, Billmyre RB, et al. Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus
Genus. mSphere. 2017;2e00238-17.
10. Kwon-Chung KJ, Bennett JE, Rhodes JC. Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek. 1982;48:25-38.
11. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol. 1999;37:838-40.
12. Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. (1557) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremel-
lomycetidae). Taxon. 2002;51:804-6.
13. Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I, Sionov E, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol.
2015;78:16-48.
14. Viviani MA, Cogliati M, Esposto MC, Lemmer K, Tintelnot K, Colom Valiente MF, et al. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of
cryptococcosis in Europe. FEMS Yeast Res. 2006;6:614-9.
15. Guinea J, Hagen F, Pelaez T, Boekhout T, Tahoune H, Torres-Narbona M, et al. Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected
during 18 years in a single institution in Madrid, Spain. Med Mycol. 2010;48:942-8.
16. Cogliati M, Desnos-Ollivier M, McCormick-Smith I, Rickerts V, Ferreira-Paim K, Meyer W, et al. Genotypes and population genetics of Cryptococcus neoformans and Cryptococcus gattii
species complexes in Europe and the mediterranean area. Fungal Genet Biol. 2019;129:16-29.
17. CDC. Cryptococcosis Facts and Stats https://www.cdc.gov/cryptococcosis/data-research/index.html#:~:text=Each%20year%2C%20an%20estimated%20152%2C000,occur%20in%20sub%-
2DSaharan%20Africa: Centers for Disease Prevention and Control; 2024 [updated 24.04.2024] Erişim Tarihi 11.06.2025.
18. Westblade LF, Burd EM, Lockhart SR, G.W. P, Walsh TJ. Larone’s Medically Important Fungi : A Guide to Identification. 7th ed. Washington DC: ASM Press; 2023.
19. Borman AM, Johnson EM. Candida, Cryptococcus, and Other Yeasts of Medical Importance. In: Carrol KC, Pfaller MA, editors. Manual of Clinical Microbiology. 13 ed. Washington, DC: ASM
Press; 2023. p. 2328-59.
20. May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14:106-17.
21. Acar M, Sutcu M, Akturk H, Hancerli Torun S, Karagoz N, Beka H, et al. [A pediatric case of HIV who diagnosed by virtue of disseminated Cryptococcus infection]. Mikrobiyol Bul.
2016;50:471-7.
22. Mete B, Saltoglu N, Vanli E, Ozkara C, Arslan F, Mert A, et al. Simultaneous cryptococcal and tuberculous meningitis in a patient with systemic lupus erythematosus. J Microbiol Immunol
Infect. 2016;49:289-94.
23. Karaman E, Ilkit M, Kuscu F. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker (R) lateral flow assay. Mycoses.
2019;62:961-8.
24. Erturk Sengel B, Tukenmez Tigen E, Can Sarinoglu R, Midi I, Cerikcioglu N, Odabasi Z. Cryptococcus meningitis presented with multiple cerebral infarcts in an immunocompetent patient.
IDCases. 2021;24:e01154.
25. Alkaya D, Kaplan E, Ergin C, Ilkit M, Dogen A. [Investigation of Cryptococcus Colonization and Mating Genotype in Environmental Samples]. Mikrobiyol Bul. 2024;58:39-48.
26. Ergin C, Sengul M, Aksoy L, Dogen A, Sun S, Averette AF, et al. Cryptococcus neoformans Recovered From Olive Trees (Olea europaea) in Turkey Reveal Allopatry With African and South
American Lineages. Front Cell Infect Microbiol. 2019;9:384.
27. Ergin C, Sengul M, Dogen A, Ilkit M. [Prediction of the species distribution of Cryptococcus neoformans throughout Turkey]. Mikrobiyol Bul. 2019;53:233-8.
28. Cogliati M, D’Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, et al. Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin. FEMS
Yeast Res. 2016;16:fow045.
29. Ergin C, Ilkit M, Kaftanoglu O. Detection of Cryptococcus neoformans var. grubii in honeybee (Apis mellifera) colonies. Mycoses. 2004;47:431-4.
30. Ergin C, Kaleli I. [Isolation of Cryptococcus neoformans from living tree trunk hollows in Denizli City Center, Turkey]. Mikrobiyol Bul. 2010;44:79-85.
31. Ergin Ç, Şengül M, Kiriş Satılmış Ö. Türkiye’nin Güney-Batı Anadolu Bölgesindeki Ilgın (Genus: Tamarix L.) Ağaçlarında Cryptococcus neoformans Kolonizasyonu Takibi. Türk Mikrobiyol
Cem Derg. 2014;44:158-62.
32. Sengul M, Kutlu M, Dogen A, Aksoy L, Gonca S, Ilkit M, et al. [Isolation of Cryptococcus neoformans from a chesnut tree (Castanea sativa), Denizli, Turkey]. Mikrobiyol Bul. 2019;53:61-9.
33. Boral H, Metin B, Dogen A, Seyedmousavi S, Ilkit M. Overview of selected virulence attributes in Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, Trichophyton rubrum, and
Exophiala dermatitidis. Fungal Genet Biol. 2018;111:92-107.
34. Casadevall A, Coelho C, Cordero RJB, Dragotakes Q, Jung E, Vij R, et al. The capsule of Cryptococcus neoformans. Virulence. 2019;10:822-31.
35. Yoo K, Bhattacharya S, Oliveira NK, Pereira de Sa N, Matos GS, Del Poeta M, et al. With age comes resilience: how mitochondrial modulation drives age-associated fluconazole tolerance in
Cryptococcus neoformans. mBio. 2024:e0184724.
36. Abdulkareem AF, Lee HH, Ahmadi M, Martinez LR. Fungal serotype-specific differences in bacterial-yeast interactions. Virulence. 2015;6:652-7.
37. Coussement J, Heath CH, Roberts MB, Lane RJ, Spelman T, Smibert OC, et al. Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a mul-
ticentre study in 46 hospitals from Australia and New Zealand. Clin Infect Dis. 2025; 80: 817-825
38. Sababoglu Baytaroglu E, Ipek V, Gokce HI, Ayozger LEO, Olguner B. Natural disasters and the rise of zoonotic diseases: A case of post-earthquake disseminated cryptococcosis in a dog. J
Mycol Med. 2024;34:101501.
39. Singh K, İlkit M, Shokohi T, Tolooe A, Malik R, Seyedmousavi S. Cryptococcosis: emergence of Cryptococcus gattii in animals and zoonotic potential. In: Seyedmousavi S, de Hoog GS, Guillot
J, Verweij P, editors. Emerging and Epizootic Fungal Infections in Animals. Switzerland: Springer International Publishing AG; 2018. p. 249-87.
40. Lagrou K, Van Eldere J, Keuleers S, Hagen F, Merckx R, Verhaegen J, et al. Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient. J Intern Med.
2005;257:385-8.
41. Bosshard PP. Incubation of fungal cultures: how long is long enough? Mycoses. 2011;54:e539-45.
42. Clinical and Laboratory Standards Institute (CLSI). CLSI M27 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 4th Ed. 4 ed. Wayne, PA: CLSI; 2017.
43. Guinea J, Meletiadis J, Arikan-Akdagli S, Giske C, Muehlethaler K, Arendrup MC, et al. EUCAST Definitive Document E.Def 7.4. Method for the determination of broth dilution minimum
inhibitory concentrations of antifungal agents for yeasts: EUCAST; 2023.
44. Weng TP, Wang SW, Lo ST, Su SL, Hsieh M, Tsai PJ, et al. Comparative evaluation of sensititre YeastOne and VITEK2 antifungal susceptibility tests with CLSI broth microdilution method of
clinical Cryptococcus isolates in Taiwan. Microbiol Spectr. 2025;13:e0211724.
45. Liu XZ, Wang QM, Theelen B, Groenewald M, Bai FY, Boekhout T. Phylogeny of tremellomycetous yeasts and related dimorphic and filamentous basidiomycetes reconstructed from multiple
gene sequence analyses. Stud Mycol. 2015;81:1-26.
46. Kalkanci A, Sugita T, Arikan S, Yucesoy M, Ener B, Otag F, et al. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from
Turkish patients. Med Mycol. 2010;48:141-6.
47. Kaplan E, Al-Hatmi AMS, Ilkit M, Gerrits van den Ende AHG, Hagen F, Meis JF, et al. Molecular Diagnostics of Arthroconidial Yeasts, Frequent Pulmonary Opportunists. J Clin Microbiol.
2017; 56: e01427-17.
48. Kasalti B, Gulmez D. Saprochaete/Magnusiomyces: identification, virulence factors, and antifungal susceptibility of a challenging rare yeast. Braz J Microbiol. 2024;55:41-9.
49. Ersoz G, Otag F, Erturan Z, Aslan G, Kaya A, Emekdas G, et al. An outbreak of Dipodascus capitatus infection in the ICU: three case reports and review of the literature. Jpn J Infect Dis.
2004;57:248-52.
50. Koc Yildirim S, Akdogan Kittana FN, Ersoy Evans S, Alp A, Arikan-Akdagli S, Karaduman A. Identification of Malassezia Species in Basal Cell Carcinoma Lesions by Conventional and
Molecular Methods. Dermatol Pract Concept. 2024; 14: e2024175
51. Menu E, Filori Q, Dufour JC, Ranque S, L’Ollivier C. A Repertoire of the Less Common Clinical Yeasts. J Fungi (Basel). 2023; 9: 1099.
52. Ayaz CM, Gulmez D, Arikan Akdagli S, Uzun O. [A Rare Yeast: Cases of Rhodotorula mucilaginosa Infection Followed Up in a Tertiary University Hospital]. Mikrobiyol Bul. 2021;55:91-8.
53. Zhou M, Li Y, Kudinha T, Xu Y, Liu Z. Kodamaea ohmeri as an Emerging Human Pathogen: A Review and Update. Front Microbiol. 2021;12:736582.
54. Otag F, Kuyucu N, Erturan Z, Sen S, Emekdas G, Sugita T. An outbreak of Pichia ohmeri infection in the paediatric intensive care unit: case reports and review of the literature. Mycoses.
2005;48:265-9.
55. Zhou M, Yu S, Kudinha T, Xiao M, Wang H, Xu Y, et al. Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study. Infect
Drug Resist. 2019;12:1657-64.
56. Alp S, Gulmez D, Kardas RC, Karahan G, Tas Z, Gursoy G, et al. Expect the unexpected: fungemia caused by uncommon Candida species in a Turkish University Hospital. Eur J Clin Microbiol
Infect Dis. 2021;40:1539-45.
57. Ioannou P, Baliou S, Kofteridis DP. Fungemia by Wickerhamomyces anomalus-A Narrative Review. Pathogens. 2024; 13: 269.
58. Yilmaz-Semerci S, Demirel G, Tastekin A. Wickerhamomyces anomalus blood stream infection in a term newborn with pneumonia. Turk J Pediatr. 2017;59:349-5.